FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, genetic and protein engineering. Invention discloses a recombinant polypeptide, having specific immunogenic properties of isoforms Oct-1, comprising an N-end section of human Oct-1A, a linker and 6 histidine residues; as well as a method for preparing polyclonal antibodies against isoforms of Oct-1 using said polypeptide. Polypeptide has sequence MADGGAASQDESSAAAAAAADSRMNNPSETSKPSMESGDGNTGTQTNGLDFQKQPVPVGGAISTAQAQAFLGHLHQVQLAGTSLQAAAQSLNVQSKSNEESGDSQQPSQPSQQPSVQAAIPQTQLMLAGGQITGLTLTPAQQQLLLQQAQAQAQLLAAAVQQHSASQQHGAAGATISASAATPMTQIPLSQPIQIAQDLQQLQQLQQQNLNLQQAFHHHHHH.
EFFECT: present invention enables to produce antibodies binding isoforms of human Oct-1A, Oct-1L and Oct-1B and can also be used to produce antibodies with high affinity and specificity with other isoforms of Oct-1.
2 cl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
DNA SEQUENCE ENCODING POLYPEPTIDE THAT BINDS WITH MORT-1 (VARIANTS), POLYPEPTIDE (VARIANTS) AND METHOD FOR ITS PREPARING, VECTOR, METHOD FOR MODULATING LIGAND FAS-R OR TNF EFFECT ON CELLS (VARIANTS), METHOD FOR TREATMENT OF CELLS, METHOD FOR ISOLATION AND IDENTIFICATION OF PROTEINS, METHOD FOR MODULATING MORT-1-INDUCED EFFECT OR MORT-1-BINDING PROTEIN-INDUCED EFFECT ON CELLS | 1996 |
|
RU2235779C2 |
PSMA×CD3 BISPECIFIC SINGLE-CHAIN ANTIBODY HAVING INTERSPECIES SPECIFICITY | 2009 |
|
RU2559531C2 |
ANTIBODIES DIRECTED AT EPITOPES LOCATED IN AREA OF 160-200 AMINO ACID BASES OF HUMAN PRAME PROTEIN, AND THEIR APPLICATION | 2019 |
|
RU2774194C2 |
SYNTHETIC PEPTIDE FOR PREPARING MONOSPECIFIC ANTIBODIES AGAINST ISOFORM 2 OF EUKARYOTIC TRANSLATION ELONGATION FACTOR 1A | 2013 |
|
RU2562880C2 |
METHODS FOR PURIFYING HETERODIMERIC POLYSPECIFIC ANTIBODIES | 2019 |
|
RU2820588C2 |
ANTIBODIES AGAINST TAU | 2013 |
|
RU2668159C2 |
MONOCLONAL ANTIBODY AND HYBRIDOMA PRODUCING ITS | 2004 |
|
RU2312109C2 |
ANTIBODY BOUND WITH CARBONIC ANHYDRASE, AND USE THEREOF | 2017 |
|
RU2727682C1 |
ANTIBODIES RECOGNISING CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS, AND METHODS OF USING SUCH | 2007 |
|
RU2461572C2 |
ANTIBODIES FOR TREATING CANCER, IN WHICH CLAUDIN 6 IS EXPRESSED | 2012 |
|
RU2816850C2 |
Authors
Dates
2016-07-10—Published
2012-10-18—Filed